In this study, we report the first evidence that HDAC inhibition, specifically inhibition of HDAC1 and HDAC6, plays an upstream regulatory role in IKKα expression, thus leading to c-Met downregulation, which subsequently overcomes gefitinib resistance in NSCLC. The gene discussed is HDAC9; the disease is non-small cell lung carcinoma.